Genflow Biosciences PLC (GENF)

Currency in GBP
1.95
-0.05(-2.50%)
Closed·
Advertisement
Unusual trading volume
GENF is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.852.05
52 wk Range
0.553.12
Key Statistics
Bid/Ask
1.65 / 2.05
Prev. Close
2
Open
2.08
Day's Range
1.85-2.05
52 wk Range
0.55-3.12
Volume
5.3M
Average Volume (3m)
1.72M
1-Year Change
178.5714%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GENF Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Short term obligations exceed liquid assets

Genflow Biosciences PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
15/05/2026
EPS / Forecast
-- / --
Revenue / Forecast
585.61K / --
EPS Revisions
Last 90 days

Compare GENF to Peers and Sector

Metrics to compare
GENF
Peers
Sector
Relationship
P/E Ratio
−7.8x−6.7x−0.4x
PEG Ratio
−0.26−0.010.00
Price/Book
−20.1x3.3x2.6x
Price / LTM Sales
18.9x5.7x3.0x
Upside (Analyst Target)
-154.2%51.7%
Fair Value Upside
Unlock−13.3%8.8%Unlock

Genflow Biosciences plc, together with its subsidiaries, engages in the research and development of gene therapies in the United Kingdom, Belgium, and the United States. It develops drugs in pre-clinical trial stage, including GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion for the treatment of metabolic associated steatohepatitis; GF-1003, a topical delivery of SIRT6 to the skin; GF-1004, a non-human pipeline anti-aging for veterinary use; GF-1005 for the treatment of mitochondrial dysfunction and sarcopenia; and GF-1006, an ophthalmology mRNA cent SIRT6 for the treatment of cornea pathologies and glaucoma. The company was founded in 2020 and is headquartered in London, the United Kingdom.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
181.13M31.98%3.53M
Public Companies & Retail Investors
385.28M68.02%7.51M
Total
566.41M100.00%11.04M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Aberdeen Group Plc8.43%47,758,252931
Hargreaves Lansdown Asset Management Ltd.7.28%41,218,000804

FAQ

What Is the Genflow Biosciences (London: GENF) Share Price Today?

The Genflow Biosciences stock price today is 1.95 GBP.

What Stock Exchange Does Genflow Biosciences (GENF) Trade On?

Genflow Biosciences is listed and trades on the London Stock Exchange.

What Is the Ticker (Stock Symbol) for Genflow Biosciences?

The stock symbol (also called a 'ticker') for Genflow Biosciences is "GENF."

What Is the Current Genflow Biosciences Market Capitalisation?

As of today, Genflow Biosciences (London: GENF) market cap is 11.04M GBP.

What Is Genflow Biosciences's (GENF) Earnings Per Share (TTM)?

The Genflow Biosciences EPS is currently -0.00 (Trailing Twelve Months).

Is GENF a Buy or Sell From a Technical Analyst Perspective?

Based on today's Genflow Biosciences moving averages and other technical indicators, the daily buy/sell signal for GENF stock is Strong Sell.

How Many Times Has Genflow Biosciences Stock Split?

Genflow Biosciences has split 0 times. (See the GENF stock split history page for full effective split date and price information.)

How Many Employees Does Genflow Biosciences Have?

Genflow Biosciences has 5 employees, based on their latest Companies House report.

What is the current trading status of Genflow Biosciences (London: GENF)?

As of 13/07/2026, Genflow Biosciences (GENF) is trading at a share price of 1.95 GBP, with a previous close of 2.00 GBP. The stock has fluctuated within a day range of 1.85 GBP to 2.05 GBP, while its 52-week range spans from 0.55 GBP to 3.12 GBP.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.